The Big 3 Distributors

The Big 3 drug wholesalers in the U.S.--AmerisourceBergen, McKesson and Cardinal Health--are enjoying a financial boost this year thanks to the growing use of generic drugs. That's a bus they hope to ride into 2011 and beyond, when they can expect drug distribution's next big business-shaker: healthcare reform.

Among the Big 3, ASB boasted an 11 percent stock rise at the end of July, compared with three percent rises for McKesson and Cardinal Health, according to Reuters. On the Fortune 500 list, McKesson holds the 14th spot, Cardinal pulls in at 17th, and ASB garners the 24th spot. Click here to begin the report >>

Suggested Articles

Hospital-backed Civica Rx has struck a deal for a CDMO to help it develop its own brand of drugs, for which it will own the rights.

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.